General
Preferred name
tapinarof
Synonyms
3,5-DIHYDROXY-4-ISOPROPYLSTILBENE ()
GSK2894512 ()
Benvitimod ()
WBI 1001 ()
WBI-1001 ()
542358 3,5-Dihydroxy-4-isopropylstilbene ()
GSK2894512, Benvitimod, WBI 1001, DHPS, DMVT 505 ()
Vtama ()
GSK-2894512 ()
P&D ID
PD064805
CAS
79338-84-4
Tags
available
drug
Approved by
FDA
First approval
2022
Drug Status
investigational
approved
Max Phase
4.0
Drug indication
atopic eczema
Probe control
Probe control not defined
Orthogonal probes
0
No orthogonal probes found
Similar probes
0
No structurally similar probes found
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Description
(extracted from source data)
DESCRIPTION
Tapinarof (WBI-1001) is a natural aryl hydrocarbon receptor (AhR) agonist with an EC50 of 13 nM. Tapinarof resolves skin inflammation in mice[1].
PRICE
77
DESCRIPTION
Tapinarof (GSK2894512) is an aryl hydrocarbon receptor (AhR) agonist . It is a naturally occurring polyphenol derived from bacteria that exist symbiotically with entomopathogenic nematodes. AhR was identified as the primary molecular target based on phenotypic screening using the DiscoveRx BioMAP Diversity Plus System and confirmed using AhR knockout mice. Tapinarof was the first steroid-free topical drug in this class to be approved as a plaque psoriasis medication.
(GtoPdb)
DESCRIPTION
Tapinarof (Benvitimod) is targeted as a topical cream treatment for psoriasis, a chronic autoimmune skin disease.
(TargetMol Bioactive Compound Library)
[[ p.pathway_name ]]
[[ compound.targets[tid].gene_name ]]
Cell lines
1
Organisms
0
Compound Sets
17
AdooQ Bioactive Compound Library
Cayman Chemical Bioactives
ChEMBL Approved Drugs
ChEMBL Drugs
Concise Guide to Pharmacology 2021/22
Concise Guide to Pharmacology 2023/24
Drug Repurposing Hub
DrugBank
DrugBank Approved Drugs
DrugCentral
DrugCentral Approved Drugs
EU-OPENSCREEN Bioactive Compound Library
Guide to Pharmacology
MedChem Express Bioactive Compound Library
ReFrame library
Selleckchem Bioactive Compound Library
TargetMol Bioactive Compound Library
[[ a.name ]]
[[ ligand_id ]]
free of charge
External IDs
23
Molecular Weight
254.13
Hydrogen Bond Acceptors
2
Hydrogen Bond Donors
2
Rotatable Bonds
3
Ring Count
2
Aromatic Ring Count
2
cLogP
4.39
TPSA
40.46
Fraction CSP3
0.18
Chiral centers
0.0
Largest ring
6.0
QED
0.8
Structural alerts
0
No structural alerts detected
Custom attributes
(extracted from source data)
Target
AHR
Aryl hydrocarbon receptor
AhR,Apoptosis related
MOA
AhR
aryl hydrocarbon receptor agonist
Pathway
Immunology/Inflammation
Metabolism
Source data

